For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Carbamazepine Tablet, Chewable and its risk associated with lactation. We will also discuss the usage of Carbamazepine Tablet, Chewable and some common side effects associated with Carbamazepine Tablet, Chewable.
What is Carbamazepine Tablet, Chewable used for?
Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS, General). Trigeminal Neuralgia Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.
I am breastfeeding mother and I am using Carbamazepine Tablet, Chewable. Can it have any bad effect on my kid? Shall I search for better alternative?
Carbamazepine is the only one ingredient used in manufacturing of Carbamazepine Tablet, Chewable, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Carbamazepine it is safe to use Carbamazepine Tablet, Chewable while lactating. We suggest you to check further details below about Carbamazepine usage in breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Carbamazepine and its epoxide metabolite are transferred to breast milk. The ratio of the concentration in breast milk to that in maternal plasma is about 0.4 for carbamazepine and about 0.5 for the epoxide. The estimated doses given to the newborn during breast-feeding are in the range of 2-5 mg daily for carbamazepine and 1-2 mg daily for the epoxide. Because of the potential for serious adverse reactions in nursing infants from carbamazepine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Carbamazepine Tablet, Chewable Breastfeeding Analsys
SafeCAS Number: 298-46-4
Excreted into breast milk in moderate amount that could arrive to be significant. Most infants reported were not found of suffering clinical issues at short or long term. However, serum levels have reached a low range of therapeutic levels, with isolated cases of somnolence, poor feeding and transient liver dysfunction with associated cholestasis. One case of Deprivation Syndrome has been reported after sudden discontinuation of medication. The American Academy of Pediatrics rates it as usually compatible with Breastfeeding. Eleventh WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.
Carbamazepine Tablet, Chewable Breastfeeding Analsys - 2
CAS Number: 298-46-4
Breastfeeding during carbamazepine monotherapy does not appear to adversely affect infant growth or development, and breastfed infants had higher IQs and enhanced verbal abilities than nonbreastfed infants at 6 years of age in one study.[1] If carbamazepine is required by the mother, it is not necessarily a reason to discontinue breastfeeding. Carbamazepine has relatively high levels in breastmilk and breastfed infants have serum levels that are measurable, but usually below the anticonvulsant therapeutic range. Most infants have had no adverse reactions, but sedation, poor sucking, withdrawal reactions and 3 cases of hepatic dysfunction have been reported. These have all been complicated because of intrauterine exposure and, in some cases, concurrent drug therapy. Monitor the infant for jaundice, drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsant or psychotropic drugs. One author recommends monitoring infant serum carbamazepine levels, liver enzymes, and a complete blood count during therapy.[2]
What should I do if I am breastfeeding mother and I am already exposed to Carbamazepine Tablet, Chewable?
It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Carbamazepine Tablet, Chewable and have used it then do not panic as Carbamazepine Tablet, Chewable is mostly safe in breastfeeding and should not cause any harm to your baby.
I am nursing mother and my doctor has suggested me to use Carbamazepine Tablet, Chewable, is it safe?
Definitely, Carbamazepine Tablet, Chewable is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Carbamazepine Tablet, Chewable, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Carbamazepine Tablet, Chewable
Who can I talk to if I have questions about usage of Carbamazepine Tablet, Chewable in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week